Nautilus Biotechnology, Inc. (NAUT)

NASDAQ: NAUT · Real-Time Price · USD

2.460

+0.080 (3.36%)

May 21, 2026, 12:45 PM EDT - Market open

Nautilus Biotechnology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	313	247	212	374	225	644
Market Cap Growth	261.67%	16.41%	-43.35%	66.38%	-65.09%	209.30%
Enterprise Value	235.45	169.4	108.35	231.63	68.62	327.22
Last Close Price	2.46	1.95	1.68	2.99	1.80	5.18
PB Ratio	2.09	1.57	1.01	1.41	0.71	1.77
P/TBV Ratio	2.15	1.57	1.01	1.41	0.71	1.20
Debt / Equity Ratio	0.17	0.17	0.13	0.12	0.09	0.08
Net Debt / Equity Ratio	-0.46	-0.47	-0.48	-0.52	-0.49	-0.87
Net Debt / EBITDA Ratio	1.16	1.22	1.32	1.97	2.56	6.62
Net Debt / FCF Ratio	1.30	1.41	1.62	2.56	3.20	7.61
Quick Ratio	11.49	13.00	17.02	19.01	27.16	59.49
Current Ratio	11.85	13.33	17.40	19.39	27.57	60.09
Return on Equity (ROE)	-37.88%	-32.27%	-29.86%	-21.95%	-17.07%	-30.14%
Return on Assets (ROA)	-34.76%	-30.81%	-29.72%	-23.23%	-17.00%	-20.89%
Return on Invested Capital (ROIC)	-79.65%	-69.30%	-69.08%	-53.00%	-60.98%	-184.94%
Return on Capital Employed (ROCE)	-36.37%	-31.96%	-30.66%	-23.81%	-17.29%	-21.28%
Buyback Yield / Dilution	-0.56%	-0.66%	-0.41%	-0.26%	-47.51%	-190.36%
Total Shareholder Return	-0.56%	-0.66%	-0.41%	-0.26%	-47.51%	-190.36%

Updated Apr 28, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q